Isis and antisense make gains in 2013
This article was originally published in Scrip
Executive Summary
Isis Pharmaceuticals founder, CEO and chairman Stanley Crooke knew it would take decades for antisense to prove itself. And while it's taken a few more years than expected for others to acknowledge the technology's potential, 2013 has been a good year for antisense in general and Isis in particular.